{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:05:48Z","timestamp":1762160748304},"reference-count":23,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,12,9]],"date-time":"2008-12-09T00:00:00Z","timestamp":1228780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold> Carriers of the Huntington disease (HD) mutation develop a progressive neurodegenerative disorder after a pre\u2010clinical phase. We examined the value of <jats:sup>11<\/jats:sup>C\u2010raclopride PET (RAC) as a biomarker for pre\u2010clinical HD pathophysiology.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> In a prospective cohort study with clinical and neuropsychological assessment we collected complete RAC data in 18 pre\u2010clinical mutation carriers (HD\u2010PMC) and 11 controls. Follow\u2010up was 2\u2003years. We calculated striatal RAC binding potential (BP) to measure dopamine D2 receptor availability.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> No HD\u2010PMC had overt neuropsychological dysfunction. RAC\u2010BP in putamen was abnormal in up to 44% of HD\u2010PMC. The rate of RAC\u2010BP decline (2.6% per year) was not significantly higher than in controls. Follow\u2010up putaminal BP correlated weakly with predicted distance to onset of clinical HD (<jats:italic>P\u2003=\u2003<\/jats:italic>0.034), but the rate of decline did not. Three HD\u2010PMC developed motor abnormalities suspect for HD but did not show an increased rate of decline of putaminal BP.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Many HD\u2010PMC have striatal abnormalities but we found no clearly increased rate of D2 receptor changes around the onset of clinical HD. A longer follow\u2010up of the present study cohort is needed to establish the value of RAC\u2010BP in assessing the risk of clinical conversion from striatal D2 binding data.<\/jats:p>","DOI":"10.1111\/j.1468-1331.2008.02390.x","type":"journal-article","created":{"date-parts":[[2008,12,10]],"date-time":"2008-12-10T00:13:09Z","timestamp":1228867989000},"page":"226-231","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Changes in striatal dopamine D2 receptor binding in pre\u2010clinical Huntington\u2019s disease"],"prefix":"10.1111","volume":"16","author":[{"given":"J.C.H.","family":"Van Oostrom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.T.M.","family":"Willemsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.M.","family":"De Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.A.C.","family":"Roos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.L.","family":"Leenders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,1,14]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.31.11.872"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410390120"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410410521"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410430216"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.1.119"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/119.6.2085"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200101)49:1<29::AID-ANA7>3.0.CO;2-B"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5391.1072"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000132965.14653.D1"},{"key":"e_1_2_6_12_2","first-page":"1591","article-title":"Metabolic network abnormalities in early Huntington\u2019s disease: an [(18)F]FDG PET study","volume":"42","author":"Feigin A","year":"2001","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2007.05.082"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000176071.08694.cc"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.4.658"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2004.00241.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1006\/nimg.2001.0978"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1006\/nimg.1996.0066"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.6.883"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2396(199801)28:1<66::AID-SYN8>3.0.CO;2-A"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/122.12.2353"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awg119"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm217"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-200109000-00002"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1331.2008.02390.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1331.2008.02390.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T20:40:05Z","timestamp":1696884005000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1331.2008.02390.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,14]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1111\/j.1468-1331.2008.02390.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1331.2008.02390.x","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,14]]},"assertion":[{"value":"2009-01-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}